Abstract:Background: Natural products have a long history in drug discovery. Lycorine is an alkaloid derived from Amaryllidaceae plants, demonstrating significant pharmacological potential. Lycorine and its hydrochloride salt, lycorine hydrochloride, have shown outstanding anticancer effects both in vitro and in vivo. Purpose: This review aims to comprehensively summarize recent research advancements regarding the anticancer potential of lycorine and lycorine hydrochloride. It intends to elucidate current research limitations, optimization strategies, and future research directions to guide clinical translation. Methods: Various databases, e.g., Web of Science, PubMed, and Chinese National Knowledge Infrastructure, are systematically searched for relevant articles using keywords such as lycorine, cancer, pharmacokinetics, and toxicity. The retrieved literature is then categorized and summarized to provide an overview of the research advancements in the anticancer potential of lycorine and lycorine hydrochloride. Results: Lycorine and lycorine hydrochloride demonstrate significant anticancer activities against various types of cancer both in vitro and in vivo, employing diverse mechanisms such as inducing cell cycle arrest, triggering cellular senescence, regulating programmed cell death, inhibiting angiogenesis, suppressing metastasis, and modulating immune system. Furthermore, pharmacokinetic profiles and toxicity data are summarized. Additionally, this review discusses the druggability, limitations, optimization strategies, and target identification of lycorine, offering insights for future preclinical studies. Conclusion: The anticancer effects and safety profile of lycorine and lycorine hydrochloride suggest promising potential for clinical applications. Further research on their in-depth mechanisms and optimization strategies targeting their limitations will enhance the understanding and druggability of lycorine and lycorine hydrochloride.

Novel Lycorine Derivatives As Anticancer Agents: Synthesis and in Vitro Biological Evaluation

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Uncover the anticancer potential of lycorine

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Lycorine: A Prospective Natural Lead for Anticancer Drug Discovery.

Recent Advances In The Synthesis Of Lamellarins As Anticancer Alkaloids

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Lycorine Possesses Notable Anticancer Potentials in On-Small Cell Lung Carcinoma Cells Via Blocking Wnt/β-catenin Signaling and Epithelial-Mesenchymal Transition (EMT).

Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives As Anticancer Agents

Synthesis and Antitumor Activity Evaluation of Novel Ursolic Acid Derivatives

Synthesis and Biological Evaluation of Nitrate Derivatives of Thiocolchicine as Potential Anticancer Drugs

Synthesis and Bioactivity Evaluation of 2,3-Diaryl Acrylonitrile Derivatives As Potential Anticancer Agents

Synthesis and Antitumor Activity of a Series of Novel N-aryl-5-(2,2,2-trifluoroethoxy)-1,5-dihydro-2H-pyrrol-2-ones Derivatives

The Synthesis and Preliminary Activity Assay In Vitro of Andrographolide Derivatives

Synthesis and biological evaluation of cytotoxic activity of novel anthracene L-rhamnopyranosides.

Synthesis and Biological Evaluation of Novel 1-Aryl, 5(Phenoxy-Substituted)aryl-1,4-pentadien-3-one Derivatives

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and Anticancer Activities of Glycyrrhetinic Acid Derivatives.

Synthesis and Cytotoxicity Evaluation of New 3‐substituted 4‐(4‐methyloxy Phenyl)‐1h‐pyrrole Derivatives

Synthesis and Anticancer Activity of 3-(Substituted Aroyl)-4-(3,4,5-trimethoxyphenyl)-1H-pyrrole Derivatives.

Synthesis and antitumor activity of novel chalcone derivatives.